See the emergency feeling
Release time:
2021-04-12
went to the hospital a few days ago and felt quite a lot. I accidentally swallowed a small piece of bone that day, and I always felt that it was still in my throat. I hurried to the hospital to hang up an outpatient number. The doctor asked about the situation and gave me a list of CT . Then I began to wait for a long time.
It was finally my turn to check after about four hours, but it took half an hour to check the results in the hospital system. The outpatient doctor had already left work, so I had to hang up the number of an emergency surgeon. He logged into the system to check my check report, but the record was not updated. After some operation, he finally asked me to find a doctor who did CT to check the report, because he could only see the doctor on the basis of that report. After three or four trips back and forth, I finally got the diagnosis when it was getting dark. At the moment I saw the result, I thought to myself, I am not dying of illness, but fortunately the result is not serious, otherwise I will be delayed alive.
Lying in bed that night, I carefully recalled the course of the day and thought of myself running back and forth to find a doctor. Suddenly, the scene of the driver panting and running to the office to get the invoice popped up in my mind. I was not annoyed and even ashamed, because I found my own shortcomings.
has been in the peak for ten years and has been in the marketing department for nearly seven years. I dare not say how good I am, but I am quite familiar with the workflow here. Although dealing with different customers every day is nothing more than accounts, money and tickets, I find that these things are very similar to the work of the emergency department of the hospital. We all know that the life of emergency patients is at stake. Although my work can not directly save lives, their timeliness, cooperation, randomness and even danger have many similarities.
First and foremost is the requirement of timeliness. I can't do anything beyond my working hours, because the bank won't wait for you, the finance department can't wait for you all the time, and I can't take the system home, just like emergency patients, doctors can't do anything beyond the best rescue time. But it's also a little different. You can find a leader if you don't want to ship the goods, but it's a lot of trouble to go through the first-level reporting and various special procedures.
Followed by collaborative requirements. The delivery of a car of cement requires the full cooperation of customers, marketing department, finance department and loading department from the customer's demand to the delivery of goods, and emergency assistance also requires the cooperation of hospitals, doctors and patients. Any link is missing.
The third is randomness. People who eat whole grains may get sick and go to the emergency department. On a certain day, everyone may become our customers, so patients and customers are random.
Finally, they're all dangerous. Delaying the emergency department will kill people, and delaying production without cement may also affect the interests of customers. Generally speaking, each has its own dangers.
The most important thing is that you can only find a hospital when you are sick, and patients with imperfect hospitals can only give it time to improve. However, different enterprises have rivals eyeing up. If you are not good enough, customers will not let their interests be lost in vain. Thinking like this, I suddenly feel that my work is so important, and the direction of my efforts becomes extremely clear. (Shang Yongzhen)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page